AURKA and ovarian carcinoma: Particularly, ovarian cancer-associated cell cycle activators, namely cyclin A2 (CCNA2) and aurora kinase A (AURKA), were downregulated by E47, thereby revealing the conserved effects of E47 in ovarian cancer cells.